Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (21)

« Back to Publications

Potential of ADAM 17 Signal Peptide To Form Amyloid Aggregates in Vitro

Bhardwaj T. and Giri R., (2023), ACS Chemical Neuroscience, 14, 3818 - 3825

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

Bhardwaj T. et al, (2023), Nature Communications, 14

One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding

Kumar P. et al, (2022), Journal of Biomolecular Structure and Dynamics, 40, 10763 - 10770

Investigating the conformational dynamics of Zika virus NS4B protein

Bhardwaj T. et al, (2022), Virology, 575, 20 - 35

Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study

Kumar P. et al, (2022), Journal of Biomolecular Structure and Dynamics, 40, 3170 - 3184

Role of structural disorder in the multi-functionality of flavivirus proteins

Kapuganti SK. et al, (2022), Expert Review of Proteomics, 19, 183 - 196

Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal

Kumar P. et al, (2022), RSC Advances, 12, 5648 - 5655

Microsecond simulations and CD spectroscopy reveals the intrinsically disordered nature of SARS-CoV-2 spike-C-terminal cytoplasmic tail (residues 1242–1273) in isolation

Kumar P. et al, (2022), Virology, 566, 42 - 55

The signal peptide of the amyloid precursor protein forms amyloid-like aggregates and enhances Aβ42 aggregation

Gadhave K. et al, (2021), Cell Reports Physical Science, 2, 100599 - 100599

Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal

Kumar P. et al, (2021)

Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions

Gadhave K. et al, (2021), Microbial Pathogenesis, 158, 105041 - 105041

Salvianolic Acid B Noncovalently Interacts With Disordered c-Myc: A Computational and Spectroscopic-Based Study

Singh A. et al, (2021), Future Medicinal Chemistry, 13, 1341 - 1352

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells

Singh A. et al, (2021), Journal of Biological Chemistry, 297, 100903 - 100903

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

Bhardwaj T. et al, (2021)

Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses

Giri R. et al, (2021), Cellular and Molecular Life Sciences, 78, 1655 - 1688

Load More